NI201000139A - ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE - Google Patents

ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE

Info

Publication number
NI201000139A
NI201000139A NI201000139A NI201000139A NI201000139A NI 201000139 A NI201000139 A NI 201000139A NI 201000139 A NI201000139 A NI 201000139A NI 201000139 A NI201000139 A NI 201000139A NI 201000139 A NI201000139 A NI 201000139A
Authority
NI
Nicaragua
Prior art keywords
beta
association
blocker
current inhibitor
sinus current
Prior art date
Application number
NI201000139A
Other languages
English (en)
Inventor
Lerebours-Pigeonniere Guy
Calvet Jean-Henri
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39666229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NI201000139(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of NI201000139A publication Critical patent/NI201000139A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Asociación de un inhibidor de corriente sinusal If y de un Beta-b1oqueante, así como las composiciones farmacéuticas que la contienen. Medicamentos.
NI201000139A 2008-02-14 2010-08-12 ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE NI201000139A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0800800A FR2927538B1 (fr) 2008-02-14 2008-02-14 Association d'un inhibiteur du courant if sinusal et d'un beta-bloquant.

Publications (1)

Publication Number Publication Date
NI201000139A true NI201000139A (es) 2011-01-10

Family

ID=39666229

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201000139A NI201000139A (es) 2008-02-14 2010-08-12 ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE

Country Status (38)

Country Link
US (1) US8217030B2 (es)
EP (2) EP2090303B1 (es)
JP (2) JP2009191069A (es)
KR (1) KR101078133B1 (es)
CN (1) CN101507726B (es)
AP (1) AP2010005366A0 (es)
AR (1) AR070416A1 (es)
AU (1) AU2009200393B2 (es)
BR (1) BRPI0900470A2 (es)
CA (1) CA2654210C (es)
CO (1) CO6290712A2 (es)
CR (1) CR11628A (es)
CU (1) CU24007B1 (es)
CY (1) CY1114113T1 (es)
DK (1) DK2090303T3 (es)
EA (1) EA200900137A1 (es)
EC (1) ECSP10010402A (es)
ES (1) ES2421893T3 (es)
FR (1) FR2927538B1 (es)
GE (1) GEP20115261B (es)
HK (1) HK1137341A1 (es)
HN (1) HN2010001608A (es)
HR (1) HRP20130617T1 (es)
IL (1) IL207386A0 (es)
MA (1) MA31132B1 (es)
ME (1) ME01014B (es)
MX (1) MX2009001590A (es)
MY (1) MY149122A (es)
NI (1) NI201000139A (es)
NZ (1) NZ574843A (es)
PL (1) PL2090303T3 (es)
PT (1) PT2090303E (es)
RS (1) RS52834B (es)
SG (1) SG155130A1 (es)
SI (1) SI2090303T1 (es)
UA (1) UA99817C2 (es)
WO (1) WO2009115669A1 (es)
ZA (1) ZA200900894B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
US9674435B1 (en) * 2016-07-06 2017-06-06 Lawrence Maxwell Monari Virtual reality platforms for capturing content for virtual reality displays
KR20190001340A (ko) * 2017-06-27 2019-01-04 에리슨제약(주) 이바브라딘을 포함하는 서방성 약제학적 조성물 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503510A (ja) * 1989-11-21 1993-06-10 セプラカー・インコーポレーテツド 光学的に純粋な（ｓ）―アテノロールを含む組成物と方法
FR2681862B1 (fr) 1991-09-27 1993-11-12 Adir Cie Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
EP1426051B1 (en) * 2001-09-11 2008-07-16 Asahi Kasei Pharma Corporation Medicinal composition for prevention of or treatment for cerebrovascular disorder
ES2211846T3 (es) 2002-07-25 2004-07-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG Uso de cilobradina o sus sales farmaceuticamente aceptables para el tratamiento o la prevencion de la insuficiencia cardiaca.
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
CN101095682A (zh) * 2007-07-23 2008-01-02 北京本草天源药物研究院 一种伊伐布雷定或其药用盐的口服制剂

Also Published As

Publication number Publication date
KR20090088328A (ko) 2009-08-19
CO6290712A2 (es) 2011-06-20
US20090209515A1 (en) 2009-08-20
AP2010005366A0 (en) 2010-08-31
DK2090303T3 (da) 2013-07-29
AR070416A1 (es) 2010-04-07
WO2009115669A1 (fr) 2009-09-24
EP2090303B1 (fr) 2013-05-01
AU2009200393B2 (en) 2013-11-07
HN2010001608A (es) 2013-10-07
CY1114113T1 (el) 2016-07-27
CR11628A (es) 2010-11-22
JP2012211179A (ja) 2012-11-01
CA2654210A1 (fr) 2009-08-14
CN101507726B (zh) 2012-03-28
US8217030B2 (en) 2012-07-10
BRPI0900470A2 (pt) 2009-09-29
HRP20130617T1 (en) 2013-07-31
PL2090303T3 (pl) 2013-07-31
FR2927538A1 (fr) 2009-08-21
MA31132B1 (fr) 2010-02-01
CA2654210C (fr) 2013-06-25
CU20100162A7 (es) 2011-10-31
RS52834B (en) 2013-10-31
FR2927538B1 (fr) 2010-02-19
EP2409694A1 (fr) 2012-01-25
ES2421893T3 (es) 2013-09-06
GEP20115261B (en) 2011-08-10
MX2009001590A (es) 2009-08-24
ECSP10010402A (es) 2010-09-30
AU2009200393A1 (en) 2009-09-03
MY149122A (en) 2013-07-15
CN101507726A (zh) 2009-08-19
KR101078133B1 (ko) 2011-10-28
ME01014B (me) 2012-10-20
EP2090303A1 (fr) 2009-08-19
JP2009191069A (ja) 2009-08-27
CU24007B1 (es) 2014-06-27
SG155130A1 (en) 2009-09-30
EA200900137A1 (ru) 2009-10-30
NZ574843A (en) 2011-07-29
UA99817C2 (ru) 2012-10-10
HK1137341A1 (en) 2010-07-30
SI2090303T1 (en) 2013-08-30
PT2090303E (pt) 2013-05-31
ZA200900894B (en) 2009-12-30
IL207386A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
HN2006018410A (es) Nuevos derivados del fluoreno, composiciones que los contienen y utilizacion
HN2006000668A (es) Compuestos de quinolina heteroaromaticos
UY3723Q (es) Aerosol
PA8667201A1 (es) Nuevos compuestos farmaceuticos
UY34216A (es) Nuevos compuestos que inhiben la actividad de la Lp-PLA2
UY31688A1 (es) Plaguicidas
CR20120008A (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
HN2008001723A (es) Nitrilos espirociclicos como inhibidores de proteasa
UY34730A (es) Formulaciones farmacéuticas que comprenden antagonistas de ccr3
HN2009000856A (es) Pirazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion.
UY31273A1 (es) Fenilendiaminas sustituidas como inhibidores de la interaccion entre mdm2 y p53
GT201300041A (es) Composicion fungicida sinergista
MA32461B1 (fr) Dronedarone pour la prevention de cardioversion
CO6761388A2 (es) Composiciones pharmaceuticas que comprenden alisporivir
UY30023A1 (es) Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen
CL2009001973S1 (es) Mostrador.
NI201000139A (es) ASOCIACION DE UN INHIBIDOR DE CORRIENTE SINUSAL If Y DE UN BETA-BLOQUEANTE
PA8795401A1 (es) Asociacion entre un antiaterotrombotico y un inhibidor de la enzima de conversion de la angiotensina
CL2012001759A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica.
CR20150073A (es) Nuevos derivados de piridina
RS53014B (en) 4R, 5S-ENANTIOMER 2- (5-METHYL-2-OXO-4-PHENYL-PYROLIDIN-1-IL) -ACETAMIDE WITH NOOTROPIC ACTIVITY
SV2010003644A (es) Asociacion de un inhibidor de corriente sinusal if y de un beta-bloqueante
ECSP099494A (es) Derivados de oxindol sustituido y medicamentos que los comprenden
CL2008001867S1 (es) Contenedor.
CL2009002112A1 (es) Un compuesto derivado de carbamoiloxi-arilalcanoil-arilpiperazina; composicion farmaceutica que comprende a dicho compuesto, util para el tratamiento del dolor, la ansiedad o la depresion.